Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.
D001402:B-Lymphocytes / Q000473:pathology; D001666:Binding Sites, Antibody; D002051:Burkitt Lymphoma / Q000473:pathology; D003165:Complement System Proteins / Q000378:metabolism; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D006362:Heavy Chain Disease / Q000473:pathology; D006689:Hodgkin Disease / Q000473:pathology*; D006801:Humans; D007141:Immunoglobulin Fc Fragments; D007519:Isoantigens / Q000032:analysis; D007938:Leukemia / Q000473:pathology*; D008206:Lymphatic Diseases / Q000473:pathology; D008223:Lymphoma / Q000473:pathology*; D009000:Monocytes / Q000473:pathology; D009182:Mycosis Fungoides / Q000473:pathology; D010587:Phagocytosis; D011947:Receptors, Antigen, B-Cell / Q000032:analysis; D012397:Rosette Formation; D012751:Sezary Syndrome / Q000473:pathology; D013601:T-Lymphocytes / Q000473:pathology
D007141:Immunoglobulin Fc Fragments; D007519:Isoantigens; D011947:Receptors, Antigen, B-Cell; D003165:Complement System Proteins; D004259:DNA-Directed DNA Polymerase